4
Changes in Ownership
Atea Pharmaceuticals, Inc. Filed Acc 0000950170-24-010970
Chief Medical Officer sold 15,870 shares at $3.84 ($60,963)
- Chief Medical Officer acquired 41,534 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Horga Maria Arantxa Chief Medical Officer | 2024-01-31 | Option exercise | +41,534 | 41,534 | D | ||
| Horga Maria Arantxa Chief Medical Officer | 2024-02-01 | Sale | −15,870 | $3.84 | $60,963 | 25,664 | D |
| Derivatives | |||||||
| Horga Maria Arantxa Chief Medical Officer | 2024-01-31 | Option exercise · Restricted Stock Units | −41,534 | 83,066 | D | ||
| Horga Maria Arantxa Chief Medical Officer | 2024-01-31 | Grant or award · Stock Option (Right to Buy) | +192,800 | 192,800 | D | ||
| Open-market sales · 15,870 sh · avg $3.84 · $60,963 | |||||||
Loading xslF345X05/ownership.xml…